NYMOX PHARMACEUTICAL CORPORATION Bank And Similar Charges
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Bank And Similar Charges of -$226.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:BankAndSimilarCharges · last filed 2025-06-03
| Period end | Bank And Similar Charges 12 month | Bank And Similar Charges 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$226.00K 20-F · filed 2025-06-03 | |
| 2023-12-31 | -$58.00K 20-F · filed 2025-06-03 | |
| 2022-12-31 | -$28.00K 20-F · filed 2025-06-03 | $28.00K 20-F · filed 2023-05-02 |
| 2021-12-31 | -$20.00K 20-F · filed 2024-08-29 | $20.00K 20-F · filed 2022-03-30 |
| 2020-12-31 | $30.00K 20-F · filed 2023-05-02 | |
| 2019-12-31 | $18.00K 20-F · filed 2022-03-30 | -$18.00K 20-F · filed 2020-03-30 |
| 2018-12-31 | $18.00K 20-F · filed 2021-03-29 | -$18.00K 20-F · filed 2019-03-29 |
| 2017-12-31 | -$52.00K 20-F · filed 2020-03-30 | |
| 2016-12-31 | -$118.00K 20-F · filed 2019-03-29 | |
| 2015-12-31 | -$92.00K 20-F · filed 2018-03-30 |